Vienna, Austria – 04 May 2021 – AG, a spin-off company of the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), today announced that it has established its operations with seed financing of EUR 1.5 million from data AG. The Company is developing a high-throughput 3D screening platform for heart...
Continue Reading